Oruka posts Phase 2 win in psoriasis, hoping to compete with Skyrizinews2026-04-27T14:19:00+00:00April 27th, 2026|Endpoints News|
What really matters about construction quality when buying a condo in Phuketnews2026-04-27T13:42:02+00:00April 27th, 2026|Medical Device News Magazine|
Carbon-free ferrocene analogue synthesisednews2026-04-27T13:30:00+00:00April 27th, 2026|Chemistry World|
Building the Future of Biotechnology — UK Biotech Day 2026news2026-04-27T13:22:40+00:00April 27th, 2026|Medical Device News Magazine|
Lilly announces a new cancer deal, paying Ajax up to $2.3B for JAK inhibitornews2026-04-27T12:36:19+00:00April 27th, 2026|Endpoints News|
Compass Therapeutics unveils key secondary endpoint results from pivotal biliary tract cancer trialnews2026-04-27T11:30:28+00:00April 27th, 2026|Endpoints News|
Intellia’s in vivo CRISPR therapy first to succeed in Phase 3news2026-04-27T11:01:29+00:00April 27th, 2026|Endpoints News|
Veradermics wins at growing hair with oral Rogaine in first key test as a public companynews2026-04-27T11:00:29+00:00April 27th, 2026|Endpoints News|
